Current batch by strength 5mg+5mg Batch 002 10mg+10mg Batch 002 Use this map to match the strength and vial batch code to the testing record shown on this page
Designed to retain the fat-reducing effects of HGH without influencing growth or insulin-like growth factor 1 levels, AOD9604 has gained attention for its potential as an anti-obesity and metabolic treatment
The pro-peptide stacked FDA advisory committee voted to lift the ban for BPC-157, and others, as expected
Tirzepatide may be better if you: Need a medication available right now : Tirzepatide is FDA-approved and available today through clinics and pharmacies Are sensitive to GI side effects : Lower overall side effect rates at every dose level Want established safety data : Years of post-marketing surveillance data available Have insurance coverage : Mounjaro/Zepbound may be partially covered Prefer a simpler titration : Uniform 2.5 mg steps are predictable and easy to follow Are a first-time incretin user : Extensive prescriber experience means better clinical support Retatrutide may be better if you: Have significant fatty liver disease : Liver fat reduction of up to 86% is unmatched Need maximum weight loss : 28.7% at 68 weeks exceeds all other compounds Have plateaued on tirzepatide : The glucagon component offers a new mechanism Are focused on metabolic health beyond weight : Triple agonism impacts more metabolic pathways Can tolerate higher GI burden : More side effects but more results Can wait for FDA approval : Expected late 2026-2027 for regulated access Neither compound is appropriate if you: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Are pregnant or planning pregnancy Have a history of severe psychiatric reactions to incretin therapies Have pancreatitis history (use with extreme caution) For researchers still undecided, the semaglutide vs tirzepatide comparison page provides additional context on how dual agonists compare to single agonists
Every batch of Cagrilintide is third-party HPLC tested to confirm purity of 99% or higher
More concerning, humanin was eventually linked to breast and brain cancers
